Loading
institutionsInstitution
Ghent University Hospital / Cancer Research Institute Ghent
Ghent's OECI-accredited university cancer centre, known for neuroblastoma genomics, early-phase trials and immuno-oncology.
Also called: UZ GentCRIGKankercentrum UZ Gent
Overview
The Cancer Centre of Ghent University Hospital is accredited by the OECI and works with the Cancer Research Institute Ghent (CRIG), which federates cancer research across Ghent University, the hospital and VIB. Frank Speleman and Katleen De Preter's groups have made major contributions to the genomics of neuroblastoma and the role of MYCN and ALK, and the Drug Research Unit Ghent under Sylvie Rottey is one of Belgium's most active phase 1 sites. Clinical strengths include head and neck and thoracic oncology, urology, melanoma immunotherapy and paediatric haemato-oncology. The hospital runs a regional radiotherapy programme and molecular tumour board.
Location
Ghent, BE
Type
hospital · Ghent University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#227 · 26 points (0 Newsweek + 0 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Ghent University Hospital, including child institutions. 495 works · 5,334 citations · 75% open access · 11% clinical trials · 4% reviews.
Oncology works per year
1022022
1142023
882024
872025
1042026
Most works
- Frederik Berrevoet29 works
- Karen Geboes27 works
- Hannelore Denys25 works
- Sylvie Rottey25 works
- Liève Brochez22 works
- Evelyne Meyer19 works
- Julie Bellemans19 works
- Fritz Offner19 works
- Laurence Finot18 works
- Marion Boutinaud18 works
Most cited
- Neuroblastoma genomics
- Drug Research Unit Ghent (phase 1)
- Immuno-oncology
- Head and neck oncology
Frank Vermassen
Representative of Ghent University Hospital / Cancer Research Institute Ghent to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Frank Vermassen represents Ghent University Hospital / Cancer Research Institute Ghent in the Organisation of European Cancer Institutes, which lists the centre among its members in Belgium.
Karim Vermaelen
Chairperson, CRIG Steering Committee (2026-2028)
Thoracic oncologyTumour immunologyImmunotherapy
Thoracic oncologist and tumour immunologist who chairs the Cancer Research Institute Ghent at Ghent University / UZ Gent.
Similar pages
- JournalOncoimmunology
- PersonYael P. Mossé
Shares ALK, Neuroblastoma (paediatric), Small-molecule kinase inhibitors.
- TargetFBLN2
Shares Neuroblastoma (paediatric), Head and neck squamous cell carcinoma, Prostate cancer.
- InstitutionIstanbul University Institute of Oncology
Shares Neuroblastoma (paediatric), Comprehensive genomic profiling, Head and neck squamous cell carcinoma.
- PersonJohn M. Maris
Shares ALK, Neuroblastoma (paediatric).
- InstitutionShanghai Pulmonary Hospital
Shares ALK, Small-molecule kinase inhibitors, Immune checkpoint inhibitors.
- CompanyInivata
Shares ALK, Comprehensive genomic profiling, Head and neck squamous cell carcinoma.
- TargetPHOX2B
Shares Neuroblastoma (paediatric), Melanoma.